Udenafil is a phosphodiesterase type 5 (PDE5) inhibitor primarily indicated for the treatment of erectile dysfunction, functioning by promoting smooth muscle relaxation and enhancing blood flow. In pharmaceutical… Read more
![Chemical structure of 3-[[[5-(Aminocarbonyl)-1-methyl-3-propyl-1H-pyrazol-4-yl]amino]carbonyl]-4-propoxy-benzenesulfonyl Chloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F374776-34-8-3-5-Aminocarbonyl-1-methyl-3-propyl-1H-pyrazol-4-ylaminocarbonyl-4-propoxy-benzenesulfonyl-Chloride.png&w=3840&q=75)
![Chemical structure of S-des[2-(1-Methyl-2-pyrrolidinyl)ethyl]amine S-Hydroxy Udenafil](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2761158-33-0-S-des2-1-Methyl-2-pyrrolidinylethylamine-S-Hydroxy-Udenafil.png&w=3840&q=75)



Udenafil is a phosphodiesterase type 5 (PDE5) inhibitor primarily indicated for the treatment of erectile dysfunction, functioning by promoting smooth muscle relaxation and enhancing blood flow. In pharmaceutical research and development, maintaining rigorous quality standards is essential, which necessitates the use of high-quality reference standards. This collection provides essential materials for comprehensive analytical testing, including impurity profiling and method validation. Laboratories utilize this range of Udenafil-related compounds—which encompasses pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites—to identify and quantify potential by-products throughout the drug manufacturing lifecycle. Additionally, stable isotope labelled compounds, such as Udenafil-d7, are critical for use as internal standards in mass spectrometry-based bioanalytical assays, ensuring accurate quantification and consistent results during stability studies and quality control assessments of the active pharmaceutical ingredient.